# BRIEFING — 2026-09-09T19:33:30+03:30

## Mission
Review Milestone 0 Deliverables 02, 03, 06, 07, and 08 (Architecture & Benchmarks Review) for Rahnab Pharmed Corporate Website project.

## 🔒 My Identity
- Archetype: reviewer & critic
- Roles: reviewer, critic
- Working directory: /Users/user/Sites/localhost/rahnab/.agents/reviewer_m0_2
- Original parent: e94d1606-4030-40be-9956-d0ddcc68d422
- Milestone: Milestone 0 (Orientation & Research)
- Instance: 2 of 2

## 🔒 Key Constraints
- Review-only — do NOT modify implementation code or deliverable files directly
- Check for integrity violations (hardcoded results, dummy implementations, shortcuts, fabricated verification, self-certifying work) -> If found, verdict must be REQUEST_CHANGES with Critical finding tagged INTEGRITY VIOLATION
- File for delivery, message for coordination
- Handoff report in handoff.md with 5 components (Observation, Logic Chain, Caveats, Conclusion, Verification Method)
- Issue an explicit verdict: APPROVE or REQUEST_CHANGES

## Current Parent
- Conversation ID: e94d1606-4030-40be-9956-d0ddcc68d422
- Updated: 2026-09-09T19:33:30+03:30

## Review Scope
- **Files to review**:
  - `/Users/user/Sites/localhost/rahnab/.agents/orchestrator_m0/deliverables/02_SUBSIDIARY_RESEARCH.md`
  - `/Users/user/Sites/localhost/rahnab/.agents/orchestrator_m0/deliverables/03_BENCHMARK_MATRIX.md`
  - `/Users/user/Sites/localhost/rahnab/.agents/orchestrator_m0/deliverables/06_INITIAL_IA_PROPOSAL.md`
  - `/Users/user/Sites/localhost/rahnab/.agents/orchestrator_m0/deliverables/07_RISK_LIST.md`
  - `/Users/user/Sites/localhost/rahnab/.agents/orchestrator_m0/deliverables/08_FULL_MILESTONE_PLAN.md`
- **Interface contracts**:
  - `docs/MASTER_PROJECT_BRIEF.md`
  - `.agents/ORIGINAL_REQUEST.md`
  - `.agents/rules/`
- **Review criteria**:
  - 1. Subsidiary Research (7 companies verified, naming discrepancies, national IDs, citations, CLIENT CONFIRMATION REQUIRED)
  - 2. Benchmark Matrix (CinnaGen + 6 international, 14 dimensions, WHY IT WORKS, holding vs operating, DO's and DON'Ts)
  - 3. Initial IA Proposal (extensibility >7 and entity types, CPT model, sitemap, URLs, navigation)
  - 4. Risk List (Technical, Design, Content, Timeline, RTL/LTR, mitigations)
  - 5. Full Milestone Plan (M1-M8 roadmap, inputs/outputs/activities/decision gates)

## Key Decisions Made
- Confirmed zero integrity violations across all deliverables.
- Verified forensic legal entity registrations and national IDs for all domestic subsidiaries.
- Validated the structural distinction between operating companies (CinnaGen) and investment holdings (Rahnab).
- Endorsed the CPT Companion Plugin model (`rahnab-core-entities`) and Latin slug policy.
- Issued official verdict: **APPROVE**.

## Artifact Index
- `/Users/user/Sites/localhost/rahnab/.agents/reviewer_m0_2/BRIEFING.md` — Working memory
- `/Users/user/Sites/localhost/rahnab/.agents/reviewer_m0_2/progress.md` — Liveness & heartbeat
- `/Users/user/Sites/localhost/rahnab/.agents/reviewer_m0_2/DISPATCH.md` — Inbound message log
- `/Users/user/Sites/localhost/rahnab/.agents/reviewer_m0_2/handoff.md` — Final review report & verdict

## Review Checklist
- **Items reviewed**: Deliverables 02, 03, 06, 07, 08 + supporting explorer reports
- **Verdict**: APPROVE
- **Unverified claims**: Candidate identity of Al Salam (`alsalampharma.com` vs proprietary offshore arm) — appropriately logged as `[CLIENT CONFIRMATION REQUIRED]`

## Attack Surface
- **Hypotheses tested**:
  - CinnaGen UI cloning vulnerability (Tested: Passed via strict anti-cloning rules and holding narrative)
  - Lenis scroll & WebGL mobile drag (Tested: Passed via viewport kill-switch <768px in Deliverable 07)
  - Extensibility beyond 7 subsidiaries (Tested: Passed via CSS auto-fit grid and CPT dynamic query)
  - URL percent-encoding SEO penalty (Tested: Passed via Latin slug convention)
  - External CDN outage in Iran (Tested: Passed via 100% self-hosted local asset mandate)
- **Vulnerabilities found**: None that compromise architecture; 3 minor advisory caveats noted for Milestone 1 execution.
- **Untested angles**: Production server staging latency under peak load (deferred to Milestone 8 QA).
